Ash
PrivateLast Round
Series A
Oct 17, 2024
Total Funding Raised
$19.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ash operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in October 2024.
Ash is a healthtech company that provides an end-to-end, white-label platform for at-home health testing to other organizations.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, API Management, Compliance
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ash Comparables
Compare Ash with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ixLayer | 85% | |
| Ro | 80% | |
| LetsGetChecked | 78% |
For institutional investors. Book with your work email.
Ash Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 17, 2024 | ||||
| Seed | Dec 10, 2022 | ||||
| Seed | May 1, 2022 | ||||
| Seed | May 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ash Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XRC Labs | Seed |
| XRC Ventures | Seed |
| LoftyInc Capital Management | Seed |
| Gaingels | Seed |
| 500 Global | Seed |
| Merus Capital | Seed |
| Remedy Product Studio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 14, 2026
Revenue increased by over 100% in the last fiscal year.
- Mar 14, 2026
Job posting suggests a clear path to profitability.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 17, 2026
Ash partners with Eastern Business Forms, Inc. to leverage a broad portfolio of specimen collection cards for screening and research applications.
- partners_withAug 17, 2026
Ash partners with Ahlstrom Corporation to leverage a broad portfolio of specimen collection cards for different screening and research applications.
For institutional investors. Book with your work email.
Ash Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ash's valuation, stock price, and market status.
Is Ash a public or private company?
Ash is a private company.
What is the current stock price of Ash?
Ash is a private company, so its shares have no public market price. Caplight tracks Ash's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ash worth (valuation)?
Valuation information for Ash is not publicly available.
Can I buy Ash stock?
Ash shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ash's last funding round?
Ash's most recent funding round was Series A on October 17, 2024.
Who are the main investors in Ash?
Key investors in Ash include XRC Labs, XRC Ventures, LoftyInc Capital Management, Gaingels, 500 Global.
Will Ash IPO soon?
No public IPO plans have been announced for Ash.
How can I track Ash secondary market activity?
Caplight tracks bids, offers, and trades in Ash's shares on secondary markets.